Fidelity Investments
OGN icon

Fidelity Investments’s Organon & Co OGN Stock Holding History

Fidelity Investments’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1M Sell
1,187,549
-1,371,143
-54% -$16.4M ﹤0.01% 1950
2026
Q1 		$15.3M Buy
2,558,692
+2,523,365
+7,143% +$19M ﹤0.01% 1885
2025
Q4 		$253K Sell
35,327
-203,626
-85% -$1.61M ﹤0.01% 3328
2025
Q3 		$2.55M Sell
238,953
-685,648
-74% -$6.73M ﹤0.01% 2458
2025
Q2 		$8.95M Sell
924,601
-555,729
-38% -$5.73M ﹤0.01% 1972
2025
Q1 		$22M Sell
1,480,330
-147,713
-9% -$2.27M ﹤0.01% 1644
2024
Q4 		$24.3M Sell
1,628,043
-182,140
-10% -$2.97M ﹤0.01% 1653
2024
Q3 		$34.6M Sell
1,810,183
-977,741
-35% -$20.3M ﹤0.01% 1520
2024
Q2 		$57.7M Sell
2,787,924
-1,089,454
-28% -$21.7M ﹤0.01% 1261
2024
Q1 		$72.9M Buy
3,877,378
+493,392
+15% +$8.47M ﹤0.01% 1182
2023
Q4 		$48.8M Buy
3,383,986
+1,194,293
+55% +$16.2M ﹤0.01% 1304
2023
Q3 		$38M Buy
2,189,693
+483,257
+28% +$10.1M ﹤0.01% 1345
2023
Q2 		$35.5M Buy
1,706,436
+187,140
+12% +$4.07M ﹤0.01% 1398
2023
Q1 		$35.7M Buy
1,519,296
+44,975
+3% +$1.21M ﹤0.01% 1379
2022
Q4 		$41.2M Buy
1,474,321
+14,423
+1% +$369K ﹤0.01% 1335
2022
Q3 		$34.2M Buy
1,459,898
+77,078
+6% +$2.33M ﹤0.01% 1397
2022
Q2 		$46.7M Buy
1,382,820
+38,337
+3% +$1.34M ﹤0.01% 1297
2022
Q1 		$47M Buy
1,344,483
+8,356
+0.6% +$286K ﹤0.01% 1414
2021
Q4 		$40.7M Sell
1,336,127
-24,194
-2% -$788K ﹤0.01% 1503
2021
Q3 		$44.6M Sell
1,360,321
-61,759
-4% -$1.98M ﹤0.01% 1455
2021
Q2 		$43M Buy
+1,422,080
New +$46.8M ﹤0.01% 1519

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Fidelity Investments's OGN Position: Q2 2026 in Review

Fidelity Investments reduced its Organon & Co (OGN) stake by 54% in Q2 2026, selling an estimated $16.4M and leaving 1,187,549 shares worth $16.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1950.

Fidelity Investments first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $72.9M in Q1 2024. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Fidelity Investments held 1,187,549 shares of Organon & Co worth $16.1M as of Q2 2026.
  • Fidelity Investments sold 1,371,143 Organon & Co shares in Q2 2026, an estimated $16.4M.
  • Organon & Co made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #1950 holding.
  • Fidelity Investments first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • Fidelity Investments's Organon & Co position peaked at $72.9M in Q1 2024.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.